RFX4 | Regulatory factor X, 4 (influences HLA class II expression) | Transcription factors
| | | | | Group enriched |
MMD2 | Monocyte to macrophage differentiation-associated 2 | Predicted membrane proteins
| | | | | Group enriched |
SLC24A2 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
POU3F3 | POU class 3 homeobox 3 | Transcription factors
| | | | | Group enriched |
SOHLH1 | Spermatogenesis and oogenesis specific basic helix-loop-helix 1 | Disease related genes Transcription factors
| | | | | Group enriched |
NXPH1 | Neurexophilin 1 | Predicted secreted proteins
| | | | | Group enriched |
SCN1A | Sodium channel, voltage-gated, type I, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
SYNPR | Synaptoporin | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HEPN1 | Hepatocellular carcinoma, down-regulated 1 | | | | | | Group enriched |
HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
KCNJ4 | Potassium inwardly-rectifying channel, subfamily J, member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
ZIC5 | Zic family member 5 | Transcription factors
| | | | | Group enriched |
KIAA1045 | KIAA1045 | | | | | | Group enriched |
NKX6-2 | NK6 homeobox 2 | Transcription factors
| | | | | Group enriched |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | | | | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
EGR4 | Early growth response 4 | Transcription factors
| | | | | Group enriched |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
FOXG1 | Forkhead box G1 | Disease related genes Transcription factors
| | | | | Group enriched |
PNMA5 | Paraneoplastic Ma antigen family member 5 | | | | | | Group enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | | | | Group enriched |
CNTNAP5 | Contactin associated protein-like 5 | Predicted membrane proteins
| | | | | Group enriched |
KCNIP2 | Kv channel interacting protein 2 | | | | | | Group enriched |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CALY | Calcyon neuron-specific vesicular protein | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CDH10 | Cadherin 10, type 2 (T2-cadherin) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH9 | Cadherin 9, type 2 (T1-cadherin) | Predicted membrane proteins
| | | | | Group enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
ELAVL2 | ELAV like neuron-specific RNA binding protein 2 | | | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SEZ6L | Seizure related 6 homolog (mouse)-like | Predicted membrane proteins
| | | | | Group enriched |
ARPP21 | CAMP-regulated phosphoprotein, 21kDa | | | | | | Group enriched |
CDH18 | Cadherin 18, type 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
PPEF1 | Protein phosphatase, EF-hand calcium binding domain 1 | Enzymes Plasma proteins
| | | | | Group enriched |
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | | | | | | Group enriched |
GABRB1 | Gamma-aminobutyric acid (GABA) A receptor, beta 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
TMEM233 | Transmembrane protein 233 | Predicted membrane proteins
| | | | | Group enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CPLX2 | Complexin 2 | | | | | | Group enriched |
CSMD1 | CUB and Sushi multiple domains 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DDX25 | DEAD (Asp-Glu-Ala-Asp) box helicase 25 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DLGAP3 | Discs, large (Drosophila) homolog-associated protein 3 | | | | | | Group enriched |